Fig. 1.

Plasma methotrexate levels at 48 hours after high-dose methotrexate infusion were significantly associated with the 80G>A variants of SLC19A1 (P=0.03).

Blood Res 2016;51:50~57 https://doi.org/10.5045/br.2016.51.1.50